CNR Institutional Research Information System

ZUCCA, FABIO ANDREA

ZUCCA, FABIO ANDREA  

Istituto di Tecnologie Biomediche - ITB  

Mostra records
Risultati 1 - 20 di 50 (tempo di esecuzione: 0.055 secondi).
Titolo Data di pubblicazione Autore(i) File
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 1-gen-2023 Cai, W; Wakamatsu, K; Zucca, Fa; Wang, Q; Yang, K; Mohamadzadehonarvar, N; Srivastava, P; Tanaka, H; Holly, G; Casella, L; Ito, S; Zecca, L; Chen, X
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 1-gen-2023 Zucca F.A.; Capucciati A.; Bellei C.; Sarna M.; Sarna T.; Monzani E.; Casella L.; Zecca L.
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 1-gen-2023 Nagatsu T.; Nakashima A.; Watanabe H.; Ito S.; Wakamatsu K.; Zucca F.A.; Zecca L.; Youdim M.; Wulf M.; Riederer P.; Dijkstra J.M.
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 1-gen-2022 Wise R.M.; Wagener A.; Fietzek U.M.; Klopstock T.; Mosharov E.V.; Zucca F.A.; Sulzer D.; Zecca L.; Burbulla L.F.
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A 1-gen-2022 Carsana E.V.; Lunghi G.; Prioni S.; Mauri L.; Loberto N.; Prinetti A.; Zucca F.A.; Bassi R.; Sonnino S.; Chiricozzi E.; Duga S.; Straniero L.; Asselta R.; Soldà G.; Samarani M.; Aureli M.
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 1-gen-2022 Capucciati A.; Monzani E.; Sturini M.; Nicolis S.; Zucca F.A.; Bubacco L.; Bortolus M.; Zecca L.; Casella L.
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 1-gen-2021 Sulkowski M.; Kot M.; Badyra B.; Paluszkiewicz A.; Plonka P.M.; Sarna M.; MichalczykWetula D.; Zucca F.A.; Zecca L.; Majka M.
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 1-gen-2021 Capucciati, A; Zucca, Fa; Monzani, E; Zecca, L; Casella, L; Hofer, T
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 1-gen-2021 Cupaioli, Fa; Zucca, Fa; Caporale, C; Lesch, Kp; Passamonti, L; Zecca, L
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 1-gen-2019 Monzani, E; Nicolis, S; Dell'Acqua, S; Capucciati, A; Bacchella, C; Zucca, Fa; Mosharov, Ev; Sulzer, D; Zecca, L; Casella, L
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 1-gen-2019 Möller, He; Bossoni, L; Connor, Jr; Crichton, Rr; Does, Md; Ward, Rj; Zecca, L; Zucca, Fa; Ronen, I
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 1-gen-2019 Betts, Mj; Kirilina, E; Otaduy, Mcg; Ivanov, D; Acostacabronero, J; Callaghan, Mf; Lambert, C; Cardenasblanco, A; Pine, K; Passamonti, L; Loane, C; Keuken, Mc; Trujillo, P; Lüsebrink, F; Mattern, H; Liu, Ky; Priovoulos, N; Fliessbach, K; Dahl, Mj; Maaß, A; Madelung, Cf; Meder, D; Ehrenberg, Aj; Speck, O; Weiskopf, N; Dolan, R; Inglis, B; Tosun, D; Morawski, M; Zucca, Fa; Siebner, Hr; Mather, M; Uludag, K; Heinsen, H; Poser, Ba; Howard, R; Zecca, L; Rowe, Jb; Grinberg, Lt; Jacobs, Hil; Düzel, E; Hämmerer, D
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 1-gen-2019 Cassidy C.M.; Zucca F.A.; Girgis R.R.; Baker S.C.; Weinstein J.J.; Sharp M.E.; Bellei C.; Valmadre A.; Vanegas N.; Kegeles L.S.; Brucato G.; Kang U.J.; Sulzer D.; Zecca L.; AbiDargham A.; Horga G.
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 1-gen-2019 Seguraaguilar, J; Sulzer, D; Zucca, Fa; Zecca, L
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 1-gen-2018 Samarani, M; Loberto, N; Soldà, G; Straniero, L; Asselta, R; Duga, S; Lunghi, G; Zucca, Fa; Mauri, L; Ciampa, Mg; Schiumarini, D; Bassi, R; Giussani, P; Chiricozzi, E; Prinetti, A; Aureli, M; Sonnino, S
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 1-gen-2018 Sulzer D.; Cassidy C.; Horga G.; Kang U.J.; Fahn S.; Casella L.; Pezzoli G.; Langley J.; Hu X.P.; Zucca F.A.; Isaias I.U.; Zecca L.
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 1-gen-2018 Zucca, Fa; Vanna, R; Cupaioli, Fa; Bellei, C; De Palma, A; Di Silvestre, D; Mauri, P; Grassi, S; Prinetti, A; Casella, L; Sulzer, D; Zecca, L
Contrast mechanisms associated with neuromelanin-MRI 1-gen-2017 Trujillo P.; Summers P.E.; Ferrari E.; Zucca F.A.; Sturini M.; Mainardi L.T.; Cerutti S.; Smith A.K.; Smith S.A.; Zecca L.; Costa A.
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease 1-gen-2017 Zucca F.A.; SeguraAguilar J.; Ferrari E.; Muñoz P.; Paris I.; Sulzer D.; Sarna T.; Casella L.; Zecca L.
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease 1-gen-2017 Ferrari E.; Capucciati A.; Prada I.; Zucca F.A.; D'Arrigo G.; Pontiroli D.; Bridelli M.G.; Sturini M.; Bubacco L.; Monzani E.; Verderio C.; Zecca L.; Casella L.